Provided by Tiger Trade Technology Pte. Ltd.

Bausch + Lomb Corp.

17.15
+0.04000.23%
Volume:251.77K
Turnover:4.32M
Market Cap:6.11B
PE:-35.63
High:17.42
Open:17.25
Low:17.08
Close:17.11
52wk High:18.92
52wk Low:13.77
Shares:356.38M
Float Shares:45.50M
Volume Ratio:0.79
T/O Rate:0.55%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4814
EPS(LYR):-1.0200
ROE:-2.52%
ROA:1.83%
PB:0.96
PE(LYR):-16.81

Loading ...

Bausch + Lomb to Host Third-Quarter Results Call and Webcast

Reuters
·
Yesterday

SpyGlass Pharma Buys Santen Unit Advanced Vision Science for About $13 Million Cash

Reuters
·
Oct 01

Bausch + Lomb Presents Phase 4 MIEBO Contact Lens Wear Study at Academy 2026 Anaheim

Reuters
·
Sep 29

Analysts Offer Insights on Healthcare Companies: Bausch + Lomb Corporation (BLCO) and Longeveron (LGVN)

TIPRANKS
·
Sep 21

US FDA Sent Warning Letter to Bausch & Lomb on September 4

Reuters
·
Sep 15

Bausch + Lomb Wins EU CE Mark for SeeLyra Femtosecond Laser

Reuters
·
Sep 11

Bausch + Lomb initiated with an Outperform at Leerink

TIPRANKS
·
Sep 09

Bausch + Lomb Unveils New ESCRS Clinical Data on enVista Aspire, LuxLife IOLs, ELIOS Glaucoma Procedure

Reuters
·
Sep 03

Bausch + Lomb publishes new research on en Vista Aspire IOLs

TIPRANKS
·
Sep 02

Bausch + Lomb Study Finds enVista Aspire IOLs Deliver Strong Distance, Intermediate Vision in Real-World Use

Reuters
·
Sep 02

Sector Update: Healthcare Stocks Edge Higher Premarket Tuesday

MT Newswires Live
·
Aug 25

Bausch + Lomb Advancing Two First-in-Class Eye Health Therapies Based on Trial Results

Reuters
·
Aug 25

Bausch + Lomb Advances Dual-Action Dry Eye Drop into Phase 3 After Phase 2 Day 15 Endpoint Win

Reuters
·
Aug 25

Baxter Stock And 2 MedTech Turnaround Plays Retail Investors Are Watching

Simply Wall St.
·
Aug 17

Bausch + Lomb Files Form 3 Disclosing Director Thomas Appio Stake of 27,583 Shares

Reuters
·
Aug 15

Bausch + Lomb SVP, Controller and CAO Frederick Munsch Sells 52,900 Common Shares Worth $887,662

Reuters
·
Aug 13

Bausch + Lomb Names Thomas Appio Board Chair in Amended Filing, Replacing Brent Saunders

Reuters
·
Aug 12

Bausch + Lomb Director Andrew C. Von Eschenbach Sells 18,559 Common Shares for $306,709.22

Reuters
·
Aug 11

Press Release: Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board

Dow Jones
·
Aug 06

Did Bausch + Lomb’s Stronger Q2 and Higher 2026 Revenue Guidance Just Shift BLCO’s Investment Narrative?

Simply Wall St.
·
Aug 04